Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

UnknownPhase 4

NCT05473806

Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes

An exploratory comparison of changes in liver fibrosis through glycemic control within and between groups after administration of Pioglitazone and Evogliptin in…

South Korea28 participantsStarted 2020-09-18

Treatment: Pioglitazone 15 Mg Oral Tablet, Evogliptin 5mg

UnknownPhase 4

NCT04584242

Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepat…

The clinical study determines the effect of Evogliptin in patients with type 2 diabetes mellitus and chronic hepatitis B to confirm the improvement of hepatic f…

South Korea40 participantsStarted 2020-09-03

Treatment: gluconon tab 15mg, suganon tab 5mg